Dipyridamole: an unfulfilled promise?
Hillis
G S
GS
Department of Medicine and Therapeutics, University of Aberdeen and Aberdeen Royal Hospitals NHS Trust, Foresterhill, UK.
Jennings
K P
KP
D001241:Aspirin / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004176:Dipyridamole / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin